Literature DB >> 7528075

Frequency of metastasis in Syrian hamster tumor cells selected for low levels of "typical" multidrug resistance.

A Shtil1, A Shushanov, E Moynova, A Stavrovskaya.   

Abstract

The metastatic capability of cells at the initial stages of selection for "typical" (P-glycoprotein-mediated) multidrug resistance (MDR) was studied. Two independent sublines, 2SC/4-1 and 2SC/4-2 (11-12.4-fold resistant), and their 23- to 23.7-fold resistant 2SC/20-1 and 2SC/20-2 variants were isolated from highly tumorigenic (TrD50 = 10 cells) and highly metastatic Rous sarcoma, virus-transformed Syrian hamster fibroblast HET-SR-2SC-LNM line for resistance to colchicine. 2SC/4 cells were less tumorigenic (TrD50 = 70 cells) but as highly metastatic as parental counterparts. In contrast, both 2SC/20 variants showed a decrease in tumorigenicity (TrD50 = 320 cells) and in the capability to produce spontaneous distant metastases. 2SC/20 cells almost lost the ability to colonize lungs in experimental metastasis assay. The autophosphorylation of pp60src tyrosine kinase in 2SC/20 cells was unaltered. The results suggest that i) selection of tumor cells for low levels of "typical" MDR leads to a decrease in the frequency of spontaneous and experimental metastases, and ii) alterations of malignancy in these cells are not caused by an impairment of function of a transforming oncogene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7528075     DOI: 10.1016/S0940-2993(11)80096-5

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  2 in total

1.  Microvessel density, expression of proto-oncogenes, resistance-related proteins and incidence of metastases in primary ovarian carcinomas.

Authors:  M Volm; R Koomagi; M Kaufmann; J Mattern; G Stammler
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

2.  Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer.

Authors:  S Mohana; M Ganesan; B Agilan; R Karthikeyan; G Srithar; R Beaulah Mary; D Ananthakrishnan; D Velmurugan; N Rajendra Prasad; Suresh V Ambudkar
Journal:  Mol Biosyst       Date:  2016-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.